Compugen Stock Technical Analysis

CGEN Stock  USD 1.65  0.02  1.20%   
As of the 15th of February 2026, Compugen shows the Downside Deviation of 3.49, mean deviation of 2.95, and Risk Adjusted Performance of 0.0205. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Compugen Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Compugen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CompugenCompugen's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Compugen Analyst Consensus

Target PriceConsensus# of Analysts
5.8Strong Buy4Odds
Compugen current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Compugen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Compugen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Compugen, talking to its executives and customers, or listening to Compugen conference calls.
Compugen Analyst Advice Details
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.30)
Revenue Per Share
0.075
Quarterly Revenue Growth
(0.89)
Return On Assets
(0.18)
Return On Equity
(0.53)
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.

Compugen 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Compugen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Compugen.
0.00
11/17/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/15/2026
0.00
If you would invest  0.00  in Compugen on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Compugen or generate 0.0% return on investment in Compugen over 90 days. Compugen is related to or competes with Mettler Toledo, Alcon AG, ResMed, Haleon Plc, Cardinal Health, Becton Dickinson, and Insmed. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes ... More

Compugen Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Compugen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Compugen upside and downside potential and time the market with a certain degree of confidence.

Compugen Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Compugen's standard deviation. In reality, there are many statistical measures that can use Compugen historical prices to predict the future Compugen's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.675.89
Details
Intrinsic
Valuation
LowRealHigh
0.132.656.87
Details
4 Analysts
Consensus
LowTargetHigh
5.285.806.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.09-0.08-0.07
Details

Compugen February 15, 2026 Technical Indicators

Compugen Backtested Returns

As of now, Compugen Stock is very risky. Compugen secures Sharpe Ratio (or Efficiency) of 0.0344, which signifies that the company had a 0.0344 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Compugen, which you can use to evaluate the volatility of the firm. Please confirm Compugen's Mean Deviation of 2.95, risk adjusted performance of 0.0205, and Downside Deviation of 3.49 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%. Compugen has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.05, which signifies a somewhat significant risk relative to the market. Compugen returns are very sensitive to returns on the market. As the market goes up or down, Compugen is expected to follow. Compugen right now shows a risk of 4.22%. Please confirm Compugen total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Compugen will be following its price patterns.

Auto-correlation

    
  0.14  

Insignificant predictability

Compugen has insignificant predictability. Overlapping area represents the amount of predictability between Compugen time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Compugen price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Compugen price fluctuation can be explain by its past prices.
Correlation Coefficient0.14
Spearman Rank Test-0.1
Residual Average0.0
Price Variance0.05
Compugen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Compugen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Compugen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Compugen Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Compugen across different markets.

About Compugen Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Compugen on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Compugen based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Compugen price pattern first instead of the macroeconomic environment surrounding Compugen. By analyzing Compugen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Compugen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Compugen specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2025 2026 (projected)
PB Ratio2.672.243.62
Capex To Depreciation0.360.220.21

Compugen February 15, 2026 Technical Indicators

Most technical analysis of Compugen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Compugen from various momentum indicators to cycle indicators. When you analyze Compugen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Compugen February 15, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Compugen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.30)
Revenue Per Share
0.075
Quarterly Revenue Growth
(0.89)
Return On Assets
(0.18)
Return On Equity
(0.53)
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.